Josue Bacaltchuk, vice president of medical affairs for Latin America for Janssen, J&J's Belgian unit developing the vaccine prototype, said countries hosting the trials would also likely get preferential access to vaccines once ready.
While the detection of an antibody response is encouraging, the scientists have themselves cautioned that further investigation is necessary to determine whether the vaccine can prevent Covid-19 in immunised people.
"The vaccine's immune response documented now among volunteers is enough to counter any dose of Covid-19 that you could imagine", Gintsburg said.
Most vaccine candidates so far have not demonstrated this even if they can be transferred and stored similarly.
Health Minister, Dr. Osagie Ehanire signed the vaccine MoU with the Russian Federation's Ambassador to Nigeria, Alexey. "The immunogenicity bodes well...."
Meanwhile, Legit.ng reported that the Federal Ministry of Health has corrected earlier reports that the Russian-made COVID-19 vaccine has been given to the Nigerian Government.
The two-part vaccine is made up of two types of the human adenovirus, genetically engineered to express a key coronavirus protein and weakened so that they can not replicate or cause disease in humans. "The results in this study mimic many other preliminary vaccine trial data and show safety and efficacy in eliciting a good immunological response", said Dr. Aaron Glatt, chair of the Department of Medicine and chief of infectious diseases at Mount Sinai South Nassau in NY. Media reports say Pfizer, Johnson and Johnson, Moderna, and others will vow not to seek the government's blessing until their vaccines are proven safe and effective. We are assessing production costs for the coming months. "We will be below 10 euros", Bogillot told France Inter radio.
"We have achieved certain agreements with the leading companies and we recognise India and its potential to become one of the hubs for production of the vaccine, not just for the Indian market but also for other countries", Dmitriev added.
He said Nigeria contacted Russian Federation for right of access to its vaccine immediately the European giant announced its breakthrough.
The SEC, while recommending approval, laid down the conditions that the trial sites should be different from the sites where the present clinical trials are going on for the vaccine through the intramuscular route and that the subject should be followed up for six months for clinical and antibody assessments.
Murray's 27 helps Nuggets knot series with Clippers
The whole thing was night and day from Game 1 , and Murray admitted after the game the team was simply exhausted that night. He also shot an uncharacteristic 4-for-17 (23.5%) from the field, his worst playoff shooting performance since 2015.